Founder of PiNC TECHnique Strategy Group, a regulatory strategy consultancy supporting early and growth stage biopharma companies.

We advise founders and executive teams on regulatory development pathways, FDA engagement strategy, and risk informed program design across the drug lifecycle.

Areas of focus include early development strategy, IND enabling planning, CMC regulatory positioning, pediatric and rare disease considerations, and global regulatory alignment.

Our work emphasizes rigor, clarity, and a right first time approach to regulatory decision making.

PiNC TECHnique Strategy Group

Org chart

Teams

Offices

PiNC TECHnique Strategy Group

Org chart

Teams

Offices

Related companies